Sanofi, BEYFORTUS
As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...
RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
Two studies published in Pediatrics demonstrate safety and efficacy for the respiratory syncytial virus (RSV) preventive drug ...
The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
But unlike influenza and COVID, there were at that time no Health Canada-approved immunization options for RSV, except for ...